Reliv International, Inc., a maker of nutritional supplements that promote optimal health, today reported its financial results for the fourth quarter and full year of 2015.
Reliv reported net sales of $12.3 million for the fourth quarter of 2015, compared with net sales of $14.1 million for the fourth quarter of 2014. U.S. net sales decreased by 12.1 percent for the quarter compared with the same quarter in 2014.
Net sales outside of the United States declined 14.9 percent in the fourth quarter of 2015 compared to the prior-year quarter, with 7.3 percent of that decline due to the impact of foreign currency fluctuation as the result of a stronger U.S. dollar.
Reliv reported net sales of $51.8 million for 2015 compared with net sales of $57.3 million in 2014. U.S. net sales decreased to $40.4 million from $43.3 million, a decline of 6.8 percent.
Net sales in Reliv's foreign markets for 2015 decreased 18.8 percent compared with net sales for 2014, with 8.3 percent of the decline due to the impact of foreign currency fluctuation as the result of a stronger U.S. dollar.
The decline in net sales in Europe represented a significant portion of the decrease in foreign sales. Net sales in Europe declined by 25.4 percent in 2015 compared to the prior year, with 5.8 percent of that decline due to the impact of foreign currency fluctuation.
The net loss for 2015 was $1.2 million (loss per diluted share of $0.10) compared to net income of $725,000 (earnings per diluted share of $0.06) in 2014.
Net income for 2014 was favorably impacted by the income tax benefit in the European subsidiary as previously noted. The loss from operations for 2015 was $1.3 million compared to income from operations of $96,000 in 2014.
Selling, general and administrative expenses were $23.5 million versus $25.0 million in 2014, as the full effect of cost reductions implemented in the latter half of 2014 helped offset the impact of the sales decline.
'The results of the fourth quarter and all of 2015 are not acceptable. In order to put us back on an upward trajectory we have restructured our distributor compensation to make the home-based business opportunity more attractive,' said Robert L. Montgomery, Chairman and Chief Executive Officer.
'The previously announced changes to our compensation plan took effect on February 1, 2016. These updates represent a key initial step in our strategy for 2016 and beyond.'
Announced by Reliv last November, the updated distributor compensation plan adjusted profit level qualifications for distributors and introduced a new preferred customer program.
'The new profit level qualifications simplify the compensation structure and provide a clearer, more achievable path to advancement,' Montgomery said.
'We know from past success that this approach works, and we anticipate a greater number of distributors achieving higher ranks within the plan and driving personal and company-wide sales growth.'
Reliv had cash and cash equivalents of $3.3 million as of December 31, 2015, a decrease of $1.7 million from the balance as of December 31, 2014.
In September 2015, Reliv entered into a term loan with Enterprise Bank & Trust in the principal amount of $3.25 million and a revolving credit facility with available borrowing capacity of $3.5 million.
The proceeds of the new term loan were used to pay off the outstanding balance of principal and accrued interest under its prior term loan and revolving credit facility with BMO Harris Bank N.A.
As of December 31, 2015, Reliv had 44,590 distributors — a decrease of 7.0 percent from December 31, 2014 — of which 6,200 are Master Affiliate level and above.
The number of Master Affiliates decreased by 13.0 percent compared to the year-ago total. Master Affiliate is the level at which distributors are eligible to earn generation royalties.
About Reliv International, Inc.
Reliv International, based in Chesterfield, MO, produces nutritional supplements that promote optimal nutrition. Reliv supplements address essential nutrition,weight loss,athletic performance,digestive health, women's health, anti-aging and healthy energy.
Reliv is the exclusive provider of LunaRich® products, which optimize levels of lunasin, a soy peptide that works at the epigenetic level to promote optimal health. The company sells its products through an international network marketing system of independent distributors in 15 countries.
Get more information, facts and figures about Reliv International, click here for the Reliv International overview.